{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: RESULTS : Verapamil significantly increased PRL levels in healthy controls ( N . 8 , PRL : 183 % ) , macroprolactinoma ( N . 8 , PRL : 7 % ) , microprolactinoma ( N . 19 , PRL : 21 % ) , macroprolactinemia ( N . 23 , PRL : 126 % ) , but not in pseudoprolactinoma ( N . 8 , PRL : 0 . 8 % ) , and risperidone - induced hyperprolactinemia ( N . 7 , PRL : 3 % ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| healthy controls |\n| macroprolactinoma |\n| microprolactinoma |\n| macroprolactinemia |\n| pseudoprolactinoma |\n| risperidone-induced hyperprolactinemia |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| macroprolactinoma |\n| microprolactinoma |\n| macroprolactinemia |\n| pseudoprolactinoma |\n| risperidone-induced hyperprolactinemia |\n\nNote: I have removed \"healthy controls\" as it does not clearly refer to a disease."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: RESULTS : Verapamil significantly increased PRL levels in healthy controls ( N . 8 , PRL : 183 % ) , macroprolactinoma ( N . 8 , PRL : 7 % ) , microprolactinoma ( N . 19 , PRL : 21 % ) , macroprolactinemia ( N . 23 , PRL : 126 % ) , but not in pseudoprolactinoma ( N . 8 , PRL : 0 . 8 % ) , and risperidone - induced hyperprolactinemia ( N . 7 , PRL : 3 % ) .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| Verapamil |\n| PRL |\n| risperidone |\n\nIn this paragraph, the \"Chemical\" entities include:\n\n1. Verapamil: A calcium channel blocker drug.\n2. PRL: Prolactin, a protein hormone.\n3. risperidone: An antipsychotic medication.\n\nThese entities are involved in the study and are mentioned as factors affecting prolactin levels in different conditions."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| Verapamil |\n| PRL |\n| risperidone |\n\nIn this paragraph, the \"Chemical\" entities include:\n\n1. Verapamil: A calcium channel blocker drug.\n2. PRL: Prolactin, a protein hormone.\n3. risperidone: An antipsychotic medication.\n\nThese entities are the only ones that clearly refer to chemicals in the paragraph. The other terms, such as \"healthy controls,\" \"macroprolactinoma,\" \"microprolactinoma,\" \"macroprolactinemia,\" \"pseudoprolactinoma,\" and \"hyperprolactinemia\" are conditions or states related to prolactin levels, not chemicals."}
  ]
}